| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/07/2002 | CN1362517A Cloning process of cheirantic outer membrane protein gene |
| 08/07/2002 | CN1362416A Production process of epidermal cell inhibitor with animal skin and its use |
| 08/07/2002 | CN1362405A Nitroso compound and use of it as spin catching agent |
| 08/07/2002 | CN1088758C Tay reagent and assay method |
| 08/07/2002 | CN1088583C Stable freeze-dried formulation comprising protein and assay kit |
| 08/06/2002 | US6429360 Plant pest control |
| 08/06/2002 | US6429306 Library screening; restriction mapping, cloning, genetic engineering, gene expression; probes for diagnostic kits |
| 08/06/2002 | US6429304 Screening for agents that modulate microtubule depolymerization |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429302 Polynucleotides related to pancreatic disease |
| 08/06/2002 | US6429298 Assays for identifying functional alterations in the p53 tumor suppressor |
| 08/06/2002 | US6429290 Modulation of body weight; diagnosis; dietetics; gene expression; drug screening |
| 08/06/2002 | US6429289 Class BI and CI scavenger receptors |
| 08/06/2002 | US6429275 Functionalized silicon compounds and methods for their synthesis and use |
| 08/06/2002 | US6429199 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 08/06/2002 | US6429025 High-throughput screening assay systems in microscale fluidic devices |
| 08/06/2002 | US6429011 Neuronal apoptosis inhibitor protein gene sequence and mutations causative of spinal muscular atrophy |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6429007 Automated instrument for performing nucleic acid amplification reactions including a temperature control system which maintains two different temperatures in two reaction chambers |
| 08/06/2002 | US6429004 Transforming or transfecting a cell with a vector containing a polynucleotide which encodes a polypeptide having amidase activity useful for the production of optically active compounds |
| 08/06/2002 | US6428990 Conversion of dihomo-gamma-linolenic acid to arachidonic acid and 20:4n-3 to eicosapentaenoic acid by host cell transformed to express human delta5-desaturase enzyme |
| 08/06/2002 | US6428987 Housing having a plurality of capillaries into which fluid flowing through the flow path is divided to flow simultaneously before being recombined, and heating appartus for producing the three temperature phases of pcr |
| 08/06/2002 | US6428986 Methods for DNA amplificating and sequencing |
| 08/06/2002 | US6428983 Histone deacetylase as target for antiprotozoal agents |
| 08/06/2002 | US6428980 Involved in cell cycle regulation for use in assays screening for cell cycle modulators and use as therapeutics for controlling apoptosis, cell proliferation, etc. in disease states or for wound healing |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428976 Rapid identification of microorganisms |
| 08/06/2002 | US6428975 Validating the sterility of lipid compounds which contain quantities of antibiotics; filtering solution then incubating microbes which may be present on filtration device to observe the growth of microbes which may be present |
| 08/06/2002 | US6428972 High speed, sensitive, accuracy |
| 08/06/2002 | US6428971 Genes and proteins related to this pathway include: teichoic acid polymerase (or tap), and cdp-glycerol:poly(glycerophosphate) glycerophosphotransferase; rodc gene and proteins |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |
| 08/06/2002 | US6428964 Adding to a biological sample suspected to contain a target nucleic acid, single-stranded nucleic acids that hybridize to a region of target nucleic acid if this region is unaltered, adding an agent to degrade single stranded nucleic acids |
| 08/06/2002 | US6428963 Recovering rna from a biological tissue sample wherein the sample is not an aqueous sample of a bodily fluid, comprising heating the sample in a chaotropic solution containing guanidinum compound for 5-120 minutes to a selected temp. |
| 08/06/2002 | US6428962 Nucleic acid collection barrier method and apparatus |
| 08/06/2002 | US6428959 Translocating a fluid sample through a nanopore by applying an electric field, monitoring the current amplitude, which changes with the passage of single or double stranded molecules |
| 08/06/2002 | US6428958 Testing a biological sample for a gene encoding canine rpe65 comprising a nucleotide sequence according to seq id no. 1 having an aaga deletion mutation of nucleotides 487-490 |
| 08/06/2002 | US6428957 Sandwich hybridization assays on arrays and provides an addressable, self assembling array |
| 08/06/2002 | US6428956 Drug screening; agriculture; comparing multiple targets simultaneously against combinatorial library (rna) |
| 08/06/2002 | US6428955 DNA diagnostics based on mass spectrometry |
| 08/06/2002 | US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 08/06/2002 | US6428952 Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies |
| 08/06/2002 | US6428951 Comprising reassembly of separate fragments of monomeric enzyme wherein reassembly of monomeric enzyme fragments is operated by interaction of molecular domains fused to each monomeric enzyme fragment |
| 08/06/2002 | US6428950 Culturing glial cells which express apolipoprotein e at known level, contacting cells with compound to be tested, comparing apolipoprotein e expression of glial cells in contact with compound with apolipoprotein e expression in control culture |
| 08/06/2002 | US6428749 Biochemical reaction detection chip comprising membranous substrate with islands on one side, each including heater and temperature detector, and probe cells for immobilizing probes and detecting biochemical reaction on other side |
| 08/06/2002 | US6428667 Multichromophore fluorescent probes using DNA intercalation complexes |
| 08/06/2002 | US6428664 Biosensor |
| 08/02/2002 | WO2001055207A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2395738A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2369477A1 In vitro assay for testing gabapentinoid activity |
| 08/01/2002 | WO2002059615A2 Method for detection of the presence of prion proteins |
| 08/01/2002 | WO2002059613A2 Oomycete ftsz-mt as a target for antimicrobial-specific biocides |
| 08/01/2002 | WO2002059612A2 Animal model and cell-line expressing modified chlorine channel |
| 08/01/2002 | WO2002059611A2 Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides |
| 08/01/2002 | WO2002059610A2 Lamin alpha 4 subunit as a diagnostic indicator of malignant tumors |
| 08/01/2002 | WO2002059609A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | WO2002059606A2 Targets and therapeutic agents for the treatmnt of epstein-barr virus infection |
| 08/01/2002 | WO2002059604A2 Diagnosis and treatment of multiple sclerosis |
| 08/01/2002 | WO2002059560A2 A method and system for predicting the biological activity, including toxicology and toxicity, of substances |
| 08/01/2002 | WO2002059558A2 Means and methods for treatment evaluation |
| 08/01/2002 | WO2002059381A2 Gene for identifying individuals with familial dysautonomia |
| 08/01/2002 | WO2002059380A2 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate |
| 08/01/2002 | WO2002059379A2 Methods for detecting, grading or monitoring an $i(h. pylori) infection |
| 08/01/2002 | WO2002059378A2 Methods and compositions for identifying gene function |
| 08/01/2002 | WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | WO2002059376A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of human colon cancer |
| 08/01/2002 | WO2002059375A2 Determination of ugt2b7 gene polymorphisms for predicting ugt2b7 substrate toxicity and for optimising drug dosage |
| 08/01/2002 | WO2002059374A1 Method for identifying genes regulating desired cell phenotypes |
| 08/01/2002 | WO2002059373A2 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | WO2002059372A2 Three dimensional biochip |
| 08/01/2002 | WO2002059371A2 Genome-wide location and function of dna binding proteins |
| 08/01/2002 | WO2002059370A2 Methods for identifying compounds that modulate disorders related to nitric oxide/cgmp-dependent protein kinase signaling |
| 08/01/2002 | WO2002059369A2 Compositions and methods for the treatment of diseases related to faulty cholesterol regulation |
| 08/01/2002 | WO2002059368A1 Specific mucin expression as a marker for pancreatic cancer |
| 08/01/2002 | WO2002059367A2 Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis |
| 08/01/2002 | WO2002059365A1 Method and apparatus for simultaneous quantification of different radionuclides on the surface of a biological microarray |
| 08/01/2002 | WO2002059364A1 Nucleic hybridization assay method and device using a cleavage technique responsive to the complementary double strand or the single strand of nucleic acids or oligonucleotides |
| 08/01/2002 | WO2002059363A2 Method for detecting of prions in a sample |
| 08/01/2002 | WO2002059362A1 Method for the effective insertion of group ii introns into specific target dna sites |
| 08/01/2002 | WO2002059361A1 Use of the slug gene or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells |
| 08/01/2002 | WO2002059360A2 Ammonium sulfate for neutralization of inhibitory effects |
| 08/01/2002 | WO2002059359A2 Method for non-redundant library construction |
| 08/01/2002 | WO2002059358A2 Kit, method and microarray for determining predisposition towards osteoporosis |
| 08/01/2002 | WO2002059357A2 Assay and kit for analyzing gene expression |
| 08/01/2002 | WO2002059356A2 Method for screening compounds for activity in treating an osteoclast related bone disease |
| 08/01/2002 | WO2002059355A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | WO2002059354A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 08/01/2002 | WO2002059353A2 Two-step amplification using a program primer followed by specific primers |
| 08/01/2002 | WO2002059352A2 Methods and means for detecting enzymatic cleavage and linkage reactions |
| 08/01/2002 | WO2002059351A2 Accessing microbial diversity by ecological methods |
| 08/01/2002 | WO2002059348A2 Methods for determining the genetic affinity of microorganisms and viruses |
| 08/01/2002 | WO2002059347A2 Aberrantly methylated genes as markers of breast malignancy |
| 08/01/2002 | WO2002059344A2 Gpr54 g protein-coupled receptor |
| 08/01/2002 | WO2002059343A2 Biological markers and diagnostic tests for angiotensin converting enzyme inhibitor- and vasopeptidase inhibitor-associated angioedema |
| 08/01/2002 | WO2002059335A2 Cytoplasmic gene inhibition or gene expression in transfected plants by a tobraviral vector |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059321A2 Hepatitis c virus replicons and replicon enhanced cells |
| 08/01/2002 | WO2002059312A2 Cell adhesion proteins |
| 08/01/2002 | WO2002059311A2 Colon cancer marker |